Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

220
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
220
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

204
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
204
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Microbe-arsenic interactions in groundwater: From community evolution to functional regulation.

Ecotoxicology and environmental safety·2026
Same author

A Case of a Chronic Ectopic Pregnancy in a Patient With Negative Serum β-HCG.

Clinical case reports·2026
Same author

A multi-omics study revealed regulatory mechanism landscape of high-altitude congenital heart disease in Tibetan female patients.

Scientific reports·2026
Same author

The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2025
Same author

Rhein attenuates oxidative stress-induced injury in human ovarian granulosa cells by inhibiting the NF-κB-TNF-α/IL-6/PTGS2 inflammatory axis.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

Top ten priorities identified by healthcare professionals to support the clinical care of individuals with attention-deficit/hyperactivity disorder: A Canadian Delphi study.

PloS one·2025

相关实验视频

Updated: Jul 15, 2025

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.4K

KDM4脱甲基酶:结构,功能和抑制剂

Yuanyuan Jiang1, Lanxin Liu1, Zeng-Quan Yang2

  • 1Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R Street, HWCRC 815, Detroit, MI, 48201, USA.

Advances in experimental medicine and biology
|September 26, 2023
PubMed
概括

基因表达 KDM4 基因组脱甲基酶调节基因表达,并与癌症有关. 本综述涵盖了KDM4蛋白结构,调节,病理学中的作用以及癌症治疗的潜在治疗抑制剂.

关键词:
癌症 癌症 癌症 癌症希斯脱甲基酶的使用方法抑制剂 抑制剂 抑制剂KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4 KDM4

更多相关视频

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K

相关实验视频

Last Updated: Jul 15, 2025

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.4K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K

科学领域:

  • 生物化学 生物化学
  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
  • 分子生物学分子生物学

背景情况:

  • 基因组脱甲基酶KDM4从H3K9和H3K36中去除甲基标记,调节染色体结构和基因表达.
  • 这些酶对于转录,细胞增殖,分化,DNA修复,免疫反应和干细胞更新至关重要.
  • 失调的KDM4表达与各种血液和固体瘤有关,突出了它们的治疗潜力.

研究的目的:

  • 总结关于KDM4蛋白质结构和调节机制的当前知识.
  • 审查KDM4蛋白在人类病理过程中的变化,特别是在发育和癌症中.
  • 讨论KDM4抑制剂作为潜在的治疗剂.

主要方法:

  • 关于KDM4基因组脱甲基酶的文献综述.
  • 对KDM4蛋白结构和调节通路的分析.
  • 检查KDM4在病理条件和癌症中的参与.

主要成果:

  • 在基本的生物过程中,KDM4脱甲基酶起着至关重要的作用.
  • 异常的KDM4表达是许多癌症的标志.
  • 已经开发出各种KDM4抑制剂,并显示出治疗的前景.

结论:

  • KDM4蛋白质是关键的表观遗传调节剂,在癌症中具有重大影响.
  • 了解KDM4的结构和调节对于开发有针对性的疗法至关重要.
  • KDM4 抑制剂是癌症治疗的一个有前途的策略.